About Sign Pharma
Sign Pharma is a Healthcare company based in Mumbai (India) founded in 2011. A sourcing company supplying bulk drugs, allied chemicals, and pharmaceutical intermediates to the industry. It operates on a B2B model. Its Indian entity Sign Pharma Trade Services Private Limited reported revenue of ₹9.46 Cr. Its focus areas include Pharmaceuticals, Drug Sourcing and Bulk Chemicals. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Sign Pharma a sourcing company supplying bulk drugs, allied chemicals, and pharmaceutical intermediates to the industry through providing healthcare solutions, producing pharmaceutical products, drug sourcing, and bulk chemicals. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website signpharma.com
- Legal Name Sign Pharma Trade Services Private Limited
- Date of Incorporation 25 Sep, 2007
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹9.46 Cr
FY 2025 · -7% YoY
- Net Profit₹52.3 Lakh
FY 2025 · 6% margin
- EBITDA₹2.35 Cr
FY 2025 · 25% margin
Associated legal entities of Sign Pharma
Sign Pharma operates through Sign Pharma Trade Services Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sign Pharma Trade Services Private Limited CIN U51397MH2007PTC174485 | Active | 25 Sep 2007 | Mumbai, Maharashtra | ₹9.5 Cr | 2 | View details |
Board of directors of Sign Pharma Trade Services Private Limited (Sign Pharma)
Sign Pharma Trade Services Private Limited is the primary company behind Sign Pharma. The board of Sign Pharma Trade Services Private Limited currently have 2 directors; the longest-serving is Dhiren Chandulal Shah, appointed in 2007.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dhiren Chandulal Shah DIN 00255333 | Director | 25 Sep 2007 | 19 yrs 1 mo | Sign Pharma Trade Services Private Limited |
| Hiren Pravin Doshi DIN 01625068 | Director | 25 Sep 2007 | 19 yrs 1 mo | Sign Pharma Trade Services Private Limited |
Financials of Sign Pharma
Figures of Sign Pharma Trade Services Private Limited, the primary company behind Sign Pharma, for FY 2025. Revenue was ₹9.46 Cr (-7% year on year). Net profit was ₹52.3 Lakh (6% margin). EBITDA was ₹2.35 Cr (25% margin). Revenue has grown at a compounded annual rate of -4% over three years and -6% over five years.
- ₹9.46 CrRevenue · FY 2025 · -7% YoY
- ₹52.3 LakhNet profit · 6% margin
- ₹2.35 CrEBITDA · 25% margin
- ₹1 LakhPaid-up capital
- -4%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sign Pharma Trade Services Private Limited are on its company page.
Detailed financial statements for Sign Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Sign Pharma
Sign Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Sign Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sign Pharma
Sign Pharma was founded in 2011.
Sign Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Sign Pharma, Sign Pharma Trade Services Private Limited, reported revenue of ₹9.46 Cr for FY 2025, down 7% year on year.
Sign Pharma a sourcing company supplying bulk drugs, allied chemicals, and pharmaceutical intermediates to the industry through providing healthcare solutions, producing pharmaceutical products, drug sourcing, and bulk chemicals. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Sign Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Sign Pharma operates through Sign Pharma Trade Services Private Limited.
The legal entities of Sign Pharma currently have 2 directors, including Dhiren Chandulal Shah, Hiren Pravin Doshi.